Riskpilot← Back to searchSign inGet full accessBodylab ApS
APSActiveCVR 36560878Plastvænget 3DWholesale of other food · NACE 4638Est. 201577 employees
Revenue 2025
DKK 83,8M
+9% vs 2024
EBITDA margin
56.0%
+8% vs 2024
Equity ratio
67.2%
Financial strength
Net profit 2025
DKK 40,9M
+27% vs 2024
| Revenue | DKK 83,8M | +9% |
| EBITDA | DKK 47M | +8% |
| Net profit | DKK 40,9M | +27% |
| Total assets | DKK 222,6M | +35% |
| Equity | DKK 149,5M | +38% |
| Employees | 77 | — |
Legal name
Bodylab ApS
CVR number
36560878
Legal form
Anpartsselskab
NACE code
4638 · Wholesale of other food
Founded
5. marts 2015
Share capital
DKK 60.000
Employees
77 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et medlem af direktionen.
Company purpose
Selskabets formål er at producere og sælge kosttilskud samt al virksomhed, som efter direktionens skøn er beslægtet hermed.
Address
Plastvænget 3D
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10.050 | 13.855 | 14.679 | 28.545 | 29.760 | 35.781 | 54.473 | 52.518 | 69.855 | 76.581 | 83.825 |
| Staff expenses | -6.772 | -6.772 | -19.045 | -19.530 | -19.085 | -23.784 | -30.834 | -29.174 | -32.393 | -33.109 | -36.873 |
| EBITDA | 3.278 | 3.350 | -4.375 | 8.970 | 10.569 | 11.996 | 23.638 | 23.309 | 37.462 | 43.472 | 46.953 |
| Depreciation & amort. | 2.486 | -2.714 | -3.603 | -7.734 | -7.750 | -2.991 | -2.131 | -2.070 | -1.513 | -1.792 | -1.510 |
| EBIT | 793 | 637 | -7.977 | 1.235 | 2.819 | 9.005 | 21.508 | 21.238 | 35.949 | 41.680 | 45.443 |
| Net financials | 329 | 800 | 419 | -677 | 727 | -767 | 1.715 | 990 | 1.095 | -504 | 6.966 |
| Profit before tax | 1.122 | 1.437 | -7.558 | 558 | 3.546 | 8.238 | 23.223 | 20.698 | 37.043 | 41.176 | 52.409 |
| Tax | 302 | 318 | -1.660 | 350 | 985 | 2.027 | 5.314 | 4.783 | 8.152 | 9.065 | 11.509 |
| Net profit | 819 | 1.118 | -5.898 | 208 | 2.560 | 6.211 | 17.909 | 15.914 | 28.891 | 32.111 | 40.900 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 41.050 | 43.684 | 58.563 | 57.944 | 63.976 | 83.097 | 70.744 | 92.515 | 118.673 | 164.516 | 222.618 |
| Equity | 31.929 | 32.228 | 25.211 | 43.539 | 46.100 | 52.310 | 31.719 | 47.634 | 76.525 | 108.637 | 149.537 |
| Long-term debt | 0 | 0 | 0 | 0 | 438 | 1.204 | 1.614 | 1.614 | 1.725 | 1.779 | 1.845 |
| Short-term debt | 7.268 | 10.005 | 32.122 | 13.281 | 17.223 | 29.570 | 37.381 | 42.744 | 39.777 | 53.434 | 70.151 |
| Total debt | 9.121 | 10.005 | 32.122 | 13.281 | 17.661 | 30.774 | 38.996 | 44.358 | 41.502 | 55.213 | 71.996 |
EBITDA margin
56.0%
This company
15.8%
Market median
+254% vs market
20152025
Equity ratio
67.2%
This company
38.2%
Market median
+76% vs market
20152025
Return on equity
27.4%
This company
18.4%
Market median
+49% vs market
20152025
Net profit margin
48.8%
This company
8.1%
Market median
+502% vs market
20152025
Asset turnover
0.38×
This company
1.12×
Market median
-66% vs market
20152025
Debt / equity
0.49×
This company
0.62×
Market median
+21% vs market
20152025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
RT Management | Management | 2015 | — | — |
DC Management | Management | 2024 | — | — |
KH Management | Management | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2018 | — | — | |
| Chairman | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Scandza Danmark ApS | Company | 100.0% | 100.0% | 2023 |
| Individual | 100.0% | 100.0% | 2023 | |
| Individual | 100.0% | 100.0% | 2020 | |
| Individual | 100.0% | 100.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Scandza Danmark ApS
Bodylab ApS Board members of Bodylab ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rasmus Thorup Andersen | Management | 0 companies |
| Dennis Christian Pedersen | Management | 0 companies |
| Kenneth Huse Halvorsen | Management | 0 companies |
| Jesper Galatius | Chairman | 0 companies |
| Henrik Broksø Thulesen | Board of Directors | 0 companies |
| Lars Ivar Tretteteig | Board of Directors | 0 companies |
| Michael Møller Jensen | Board of Directors | 0 companies |
| Line Jackson Ræstad | Board of Directors | 0 companies |
| Jon Thomas Warset | Chairman | 0 companies |